America Great Health (AAGH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 204.3 Thousand USD | 95.23% |
| 2022 | 104.64 Thousand USD | -46.52% |
| 2021 | 195.67 Thousand USD | 3474.55% |
| 2020 | 5474.00 USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 3.17 Million USD | 7219.05% |
| 2015 | 43.37 Thousand USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 6627.00 USD | 47.27% |
| 2012 | 4500.00 USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 91.17 Thousand USD | 560.33% |
| 2024 Q3 | 94.03 Thousand USD | 3.13% |
| 2024 Q1 | 13.8 Thousand USD | -81.51% |
| 2023 Q4 | 74.68 Thousand USD | 89.31% |
| 2023 FY | 204.3 Thousand USD | 95.23% |
| 2023 Q1 | 51.93 Thousand USD | 196.58% |
| 2023 Q2 | 38.23 Thousand USD | -26.39% |
| 2023 Q3 | 39.45 Thousand USD | 3.2% |
| 2022 Q2 | 155.68 Thousand USD | 0.0% |
| 2022 FY | 104.64 Thousand USD | -46.52% |
| 2022 Q4 | -53.77 Thousand USD | -2059.77% |
| 2022 Q3 | 2744.00 USD | -98.24% |
| 2022 Q1 | - USD | 0.0% |
| 2021 Q3 | 195.53 Thousand USD | 0.0% |
| 2021 Q4 | - USD | -100.0% |
| 2021 FY | 195.67 Thousand USD | 3474.55% |
| 2021 Q1 | 136.00 USD | -97.52% |
| 2021 Q2 | - USD | -100.0% |
| 2020 FY | 5474.00 USD | 0.0% |
| 2020 Q4 | 5474.00 USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 100.0% |
| 2019 Q4 | -100.00 USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q1 | 100.00 USD | 0.0% |
| 2019 Q2 | - USD | -100.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 100.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 26.37 Thousand USD | -95.42% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | -26.37 Thousand USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2016 Q2 | 1.46 Million USD | 1876.85% |
| 2016 Q3 | 1.06 Million USD | -27.24% |
| 2016 Q1 | 73.9 Thousand USD | 70.4% |
| 2016 Q4 | 576.51 Thousand USD | -45.76% |
| 2016 FY | 3.17 Million USD | 7219.05% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | 43.37 Thousand USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 43.37 Thousand USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | 44.72 Thousand USD | 574.92% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q2 | - USD | -100.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 6627.00 USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 100.0% |
| 2013 FY | 6627.00 USD | 47.27% |
| 2012 Q2 | 4500.00 USD | 0.0% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | -4750.00 USD | 0.0% |
| 2012 FY | 4500.00 USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| Evolutionary Genomics, Inc. | - USD | -Infinity% |
| Innovation1 Biotech Inc. | - USD | -Infinity% |
| Point of Care Nano-Technology, Inc. | - USD | -Infinity% |
| Vicapsys Life Sciences, Inc. | - USD | -Infinity% |